Subsequent Events (Details) - USD ($) $ / shares in Units, $ in Thousands		1 Months Ended				12 Months Ended
	Mar. 01, 2022	Apr. 30, 2022	Apr. 01, 2022	Feb. 28, 2022	Feb. 28, 2022	Dec. 31, 2021
Subsequent Events (Details) [Line Items]
Exercise price						$ 10
Aggregate gross proceeds percentage						7.00%
Series B Preferred Stock [Member]
Subsequent Events (Details) [Line Items]
Initial conversion price						$ 1
Volume weighted average price, percentage						88.00%
Share at a rate						15.00%
Subsequent Event [Member]
Subsequent Events (Details) [Line Items]
Subsequent events, description	the Company consummated the Initial Closing in which the Company issued to the buyer (i) 16,125 Series B Preferred with a stated value of $1,000 per share, initially convertible into up to 16,125,000 shares of the Company’s common stock at a conversion price of $1.00 per share, and (ii) the February 2022 Warrants that are initially exercisable for up to 16,125,000 shares of the Company’s common stock, in a registered direct offering. The aggregate purchase price paid for such Series B Preferred and the February 2022 Warrants at the Initial Closing was $15,000.Pursuant to the February 2022 Purchase Agreement, an additional 5,375 Series B Preferred may be issued and sold in one or more subsequent closings (each, an “Additional Closing”), in each case subject to certain closing conditions. As a result of the issuance of the Preferred Shares and February 2022 Warrants, the exercise price of the Series A Warrant, Series B Warrant and Series D Warrant previously issued by the Company to an affiliate of the buyer will automatically adjust to $1.00 (with a proportional increase to the number of shares of the Company’s common stock issuable upon exercise of such warrants). Pursuant to the February 2022 Purchase Agreement, such affiliate of the buyer will agree to waive any further anti-dilution adjustment of such existing warrants below $1.00 as a result of the transactions contemplated by the February 2022 Purchase Agreement.			The February 2022 Warrants will be exercisable commencing on the date of issuance, and will expire five years from the date of issuance.	the Company entered into a securities purchase agreement (the “February 2022 Purchase Agreement”) with a buyer for the purchase and sale of (i) an aggregate of up to 21,500 shares of newly-designated Series B convertible preferred stock (the “Series B Preferred”) with a stated value of $1,000 per share, initially convertible into up to 21,500,000 shares of the Company’s common stock at a conversion price of $1.00 per share, and (ii) warrants (the “February 2022 Warrants”) to purchase up to that number of shares of the Company’s common stock equal to the number of shares of the Company’s common stock into which the shares of Series B Preferred actually sold pursuant to the purchase agreement are initially convertible, in a registered direct offering.Pursuant to the February 2022 Purchase Agreement, an aggregate of 16,125 shares of Series B Preferred, initially convertible into 16,125,000 shares of the Company’s common stock, together with the February 2022 Warrants, initially exercisable for 16,125,000 shares of the Company’s common stock, were to be issued and sold at an initial closing (the “Initial Closing”), and the remaining 5,375 Preferred Shares may be issued and sold in one or more subsequent closings (each, an “Additional Closing”), in each case subject to certain closing conditions. The Company can require the buyer to purchase the remaining 5,375 Preferred Shares at an Additional Closing if the Company’s stockholders approve the issuance of all securities issuable pursuant to the February 2022 Purchase Agreement in compliance with the rules and regulations of the Nasdaq Capital Market within a specified period of time after the Initial Closing, subject to certain other closing conditions (including certain equity conditions), and the buyer can require the Company to sell the remaining 5,375 Preferred Shares at one or more Additional Closings, subject to certain conditions. The purchase price for any Preferred Shares sold at an Additional Closing would be approximately $930 per share.
Exercise price				$ 1
Forecast [Member]
Subsequent Events (Details) [Line Items]
Total preferred stock shares			1,625,439
Aggregate gross proceeds percentage		5.00%
Aggregate original principal amount		$ 12,000
Purchase price		$ (10,000)
Conversion descripiton		The maturity date of the Convertible Notes is October 1, 2023, and no interest shall accrue on the Convertible Notes, unless an event of default (as defined) has occurred. From and after the occurrence and during the continuance of any such event of default, interest shall accrue at the rate of 15.0% per annum. Starting on August 1, 2022 and continuing on the first trading day of each subsequent calendar month, $800 of the Convertible Notes are eligible for conversion to shares of the Company’s common stock, subject to certain exceptions, including the option that the Company has to pay such amount in cash, and the holders’ option to convert the entire Convertible Note to shares of the Company’s common stock at any time.
Forecast [Member] | Common Stock [Member]
Subsequent Events (Details) [Line Items]
Converted shares			1,625,439